175 related articles for article (PubMed ID: 9337351)
21. Interdependence of DNA mismatch repair proteins MLH1 and MSH2 in apoptosis in human colorectal carcinoma cell lines.
Hassen S; Ali AA; Kilaparty SP; Al-Anbaky QA; Majeed W; Boman BM; Fields JZ; Ali N
Mol Cell Biochem; 2016 Jan; 412(1-2):297-305. PubMed ID: 26728996
[TBL] [Abstract][Full Text] [Related]
22. Effect of loss of DNA mismatch repair on development of topotecan-, gemcitabine-, and paclitaxel-resistant variants after exposure to cisplatin.
Lin X; Howell SB
Mol Pharmacol; 1999 Aug; 56(2):390-5. PubMed ID: 10419559
[TBL] [Abstract][Full Text] [Related]
23. Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage.
Vikhanskaya F; Colella G; Valenti M; Parodi S; D'Incalci M; Broggini M
Clin Cancer Res; 1999 Apr; 5(4):937-41. PubMed ID: 10213232
[TBL] [Abstract][Full Text] [Related]
24. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation.
Yan T; Schupp JE; Hwang HS; Wagner MW; Berry SE; Strickfaden S; Veigl ML; Sedwick WD; Boothman DA; Kinsella TJ
Cancer Res; 2001 Nov; 61(22):8290-7. PubMed ID: 11719462
[TBL] [Abstract][Full Text] [Related]
25. Brostallicin (PNU-166196)--a new DNA minor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cells.
Fedier A; Fowst C; Tursi J; Geroni C; Haller U; Marchini S; Fink D
Br J Cancer; 2003 Oct; 89(8):1559-65. PubMed ID: 14562032
[TBL] [Abstract][Full Text] [Related]
26. Reduction of spontaneous mutagenesis in mismatch repair-deficient and proficient cells by dietary antioxidants.
Mure K; Rossman TG
Mutat Res; 2001 Sep; 480-481():85-95. PubMed ID: 11506802
[TBL] [Abstract][Full Text] [Related]
27. Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin.
Moreland NJ; Illand M; Kim YT; Paul J; Brown R
Cancer Res; 1999 May; 59(9):2102-6. PubMed ID: 10232595
[TBL] [Abstract][Full Text] [Related]
28. Biallelic somatic inactivation of the mismatch repair gene MLH1 in a primary skin melanoma.
Castiglia D; Pagani E; Alvino E; Vernole P; Marra G; Cannavò E; Jiricny J; Zambruno G; D'Atri S
Genes Chromosomes Cancer; 2003 Jun; 37(2):165-75. PubMed ID: 12696065
[TBL] [Abstract][Full Text] [Related]
29. DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO cells.
Yan T; Berry SE; Desai AB; Kinsella TJ
Clin Cancer Res; 2003 Jun; 9(6):2327-34. PubMed ID: 12796402
[TBL] [Abstract][Full Text] [Related]
30. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type.
Wang Q; Montmain G; Ruano E; Upadhyaya M; Dudley S; Liskay RM; Thibodeau SN; Puisieux A
Hum Genet; 2003 Feb; 112(2):117-23. PubMed ID: 12522551
[TBL] [Abstract][Full Text] [Related]
31. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation.
Davis TW; Wilson-Van Patten C; Meyers M; Kunugi KA; Cuthill S; Reznikoff C; Garces C; Boland CR; Kinsella TJ; Fishel R; Boothman DA
Cancer Res; 1998 Feb; 58(4):767-78. PubMed ID: 9485033
[TBL] [Abstract][Full Text] [Related]
32. Measurement of DNA mismatch repair activity in live cells.
Lei X; Zhu Y; Tomkinson A; Sun L
Nucleic Acids Res; 2004 Jul; 32(12):e100. PubMed ID: 15249596
[TBL] [Abstract][Full Text] [Related]
33. Effects of hyperthermia on Hsp27 (HSPB1), Hsp72 (HSPA1A) and DNA repair proteins hMLH1 and hMSH2 in human colorectal cancer hMLH1-deficient and hMLH1-proficient cell lines.
Nadin SB; Cuello-Carrión FD; Sottile ML; Ciocca DR; Vargas-Roig LM
Int J Hyperthermia; 2012; 28(3):191-201. PubMed ID: 22515340
[TBL] [Abstract][Full Text] [Related]
34. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts.
Vaisman A; Varchenko M; Umar A; Kunkel TA; Risinger JI; Barrett JC; Hamilton TC; Chaney SG
Cancer Res; 1998 Aug; 58(16):3579-85. PubMed ID: 9721864
[TBL] [Abstract][Full Text] [Related]
35. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint.
Hawn MT; Umar A; Carethers JM; Marra G; Kunkel TA; Boland CR; Koi M
Cancer Res; 1995 Sep; 55(17):3721-5. PubMed ID: 7641183
[TBL] [Abstract][Full Text] [Related]
36. Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair.
Oki E; Oda S; Maehara Y; Sugimachi K
Oncogene; 1999 Mar; 18(12):2143-7. PubMed ID: 10321739
[TBL] [Abstract][Full Text] [Related]
37. Human mismatch-repair protein MutL homologue 1 (MLH1) interacts with Escherichia coli MutL and MutS in vivo and in vitro: a simple genetic system to assay MLH1 function.
Quaresima B; Alifano P; Tassone P; Avvedimento EV; Costanzo FS; Venuta S
Biochem J; 2003 Apr; 371(Pt 1):183-9. PubMed ID: 12513688
[TBL] [Abstract][Full Text] [Related]
38. hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents.
Brown R; Hirst GL; Gallagher WM; McIlwrath AJ; Margison GP; van der Zee AG; Anthoney DA
Oncogene; 1997 Jul; 15(1):45-52. PubMed ID: 9233776
[TBL] [Abstract][Full Text] [Related]
39. Reduced host cell reactivation of oxidative DNA damage in human cells deficient in the mismatch repair gene hMSH2.
Pitsikas P; Lee D; Rainbow AJ
Mutagenesis; 2007 May; 22(3):235-43. PubMed ID: 17351251
[TBL] [Abstract][Full Text] [Related]
40. Mismatch repair deficiency in hematological malignancies with microsatellite instability.
Gu L; Cline-Brown B; Zhang F; Qiu L; Li GM
Oncogene; 2002 Aug; 21(37):5758-64. PubMed ID: 12173046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
